In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis.
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis.
复制标题
DOI:
10.1038/s41588-023-01471-2
复制
发表时间:
2023-09
期刊:
影响因子:
30.8
通讯作者:
Huntly, Brian J. P.
中科院分区:
文献类型:
--
作者:
Lara-Astiaso, David;Goni-Salaverri, Ainhoa;Mendieta-Esteban, Julen;Narayan, Nisha;Del Valle, Cynthia;Gross, Torsten;Giotopoulos, George;Beinortas, Tumas;Navarro-Alonso, Mar;Aguado-Alvaro, Laura Pilar;Zazpe, Jon;Marchese, Francesco;Torrea, Natalia;Calvo, Isabel A.;Lopez, Cecile K.;Alignani, Diego;Lopez, Aitziber;Saez, Borja;Taylor-King, Jake P.;Prosper, Felipe;Fortelny, Nikolaus;Huntly, Brian J. P.
Cellular differentiation requires extensive alterations in chromatin structure and function, which is elicited by the coordinated action of chromatin and transcription factors. By contrast with transcription factors, the roles of chromatin factors in differentiation have not been systematically characterized. Here, we combine bulk ex vivo and single-cell in vivo CRISPR screens to characterize the role of chromatin factor families in hematopoiesis. We uncover marked lineage specificities for 142 chromatin factors, revealing functional diversity among related chromatin factors (i.e. barrier-to-autointegration factor subcomplexes) as well as shared roles for unrelated repressive complexes that restrain excessive myeloid differentiation. Using epigenetic profiling, we identify functional interactions between lineage-determining transcription factors and several chromatin factors that explain their lineage dependencies. Studying chromatin factor functions in leukemia, we show that leukemia cells engage homeostatic chromatin factor functions to block differentiation, generating specific chromatin factor–transcription factor interactions that might be therapeutically targeted. Together, our work elucidates the lineage-determining properties of chromatin factors across normal and malignant hematopoiesis. Bulk ex vivo and single-cell in vivo CRISPR knockout screens are used to characterize 680 chromatin factors during mouse hematopoiesis, highlighting lineage-specific and normal and leukemia-specific functions.
登录
查看更多内容
影响因子:
30.8
作者:
Douillet D;Sze CC;Ryan C;Piunti A;Shah AP;Ugarenko M;Marshall SA;Rendleman EJ;Zha D;Helmin KA;Zhao Z;Cao K;Morgan MA;Singer BD;Bartom ET;Smith ER;Shilatifard A
通讯作者:
Shilatifard A
DOI:
10.1073/pnas.0807297105
发表时间:
2008-09-30
影响因子:
11.1
作者:
Anderson, Ericka L.;Baltus, Andrew E.;Page, David C.
通讯作者:
Page, David C.
影响因子:
30.5
作者:
Cuartero S;Weiss FD;Dharmalingam G;Guo Y;Ing-Simmons E;Masella S;Robles-Rebollo I;Xiao X;Wang YF;Barozzi I;Djeghloul D;Amano MT;Niskanen H;Petretto E;Dowell RD;Tachibana K;Kaikkonen MU;Nasmyth KA;Lenhard B;Natoli G;Fisher AG;Merkenschlager M
通讯作者:
Merkenschlager M
影响因子:
16
作者:
Heinz S;Benner C;Spann N;Bertolino E;Lin YC;Laslo P;Cheng JX;Murre C;Singh H;Glass CK
通讯作者:
Glass CK
影响因子:
30.8
作者:
Corces, M. Ryan;Buenrostro, Jason D.;Wu, Beijing;Greenside, Peyton G.;Chan, Steven M.;Koenig, Julie L.;Snyder, Michael P.;Pritchard, Jonathan K.;Kundaje, Anshul;Gkeenleaf, William J.;Majeti, Ravindra;Chang, Howard Y.
通讯作者:
Chang, Howard Y.